Changing faces-natural course and treatment of hepatitis C after liver transplantation.
Bahr
Matthias J
MJ
Manns
Michael P
MP
D000998:Antiviral Agents / Q000008:administration & dosage; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000209:etiology* / Q000601:surgery; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D008103:Liver Cirrhosis / Q000209:etiology / Q000517:prevention & control / Q000601:surgery; D016031:Liver Transplantation / Q000009:adverse effects*; D011092:Polyethylene Glycols; D011994:Recombinant Proteins; D012008:Recurrence; D012254:Ribavirin / Q000008:administration & dosage
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C417083:peginterferon alfa-2b